No Data
Express News | Alk-Abello A/S - Alk to Pay USD 145 Mln in Upfront and Additional Future Milestones and Sales Royalties
Companies Like ARS Pharmaceuticals (NASDAQ:SPRY) Can Afford To Invest In Growth
Earnings Preview: SPRY to Report Financial Results Pre-market on November 13
$ARS Pharmaceuticals(SPRY.US)$ is scheduled to release its financial results pre-market on November 13 ET. Earnings PreviewAnalysts estimate $ARS Pharmaceuticals(SPRY.US)$ to post revenue of USD575.00
ARS Pharmaceuticals Announces Conference Call and Webcasts for Its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences
ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Here's Why We're Not At All Concerned With ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation
No Data
No Data